As of November 2024, Edwards Lifesciences has a market cap of $40.96B. This makes Edwards Lifesciences the world's 447th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $51.84B | 12.09% |
2023 | $46.25B | 2.20% |
2022 | $45.25B | -42.41% |
2021 | $78.57B | 42.00% |
2020 | $55.33B | 17.32% |
2019 | $47.16B | 52.31% |
2018 | $30.97B | 35.90% |
2017 | $22.79B | 20.29% |
2016 | $18.94B | 18.64% |
2015 | $15.97B | 24.01% |
2014 | $12.88B | 93.70% |
2013 | $6.65B | -27.07% |
2012 | $9.11B | 27.54% |
2011 | $7.15B | -12.54% |
2010 | $8.17B | 86.16% |
2009 | $4.39B | 58.05% |
2008 | $2.78B | 19.48% |
2007 | $2.32B | -2.23% |
2006 | $2.38B | 13.05% |
2005 | $2.10B | 0.85% |
2004 | $2.09B | 37.17% |
2003 | $1.52B | 18.10% |
2002 | $1.29B | -7.82% |
2001 | $1.40B | 55.66% |
2000 | $897.12M | - |